Executive Cardiovascular Screening

The Guidelines Gap

Medical societies issue guidelines based on evidence about who benefits from testing. For coronary calcium scoring, guidelines generally recommend it for intermediate-risk individuals where results would change management decisions. For low-risk patients, the test rarely changes outcomes—and adds radiation exposure, cost, and potential for anxiety or unnecessary intervention.

Luxury health services often position themselves as offering "more thorough" care than guideline-limited insurance medicine. The question is whether "more" is actually "better" when the evidence suggests guidelines are appropriately conservative.

Why It Matters for Luxury

Cardiovascular screening in low-risk populations exemplifies a tension between consumer demand and evidence-based medicine. Clients want reassurance; doctors in competitive markets want to provide it; the tests exist and are safe enough. But the fundamental question—does this testing improve outcomes in this specific population?—often remains unanswered. Luxury medicine operates in the gap between what's possible and what's proven.